Tempest announced an exclusive collaboration and license agreement with Heibei Senlang, but the filing gives no payment or royalty terms, so the announcement does not change the company's standing.
The 8-K shows Tempest signed an exclusive collaboration and license agreement with Heibei Senlang. The filing gives no payment, milestone, or royalty details, so the business consequences are unclear.
Follow Tempest Therapeutics, Inc. (TPST) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for TPST